AT323319B - Verfahren zur gefrierkonzentrierung von wässerigen lösungen niedermolekularer oder höhermolekularer arzneimittel - Google Patents

Verfahren zur gefrierkonzentrierung von wässerigen lösungen niedermolekularer oder höhermolekularer arzneimittel

Info

Publication number
AT323319B
AT323319B AT80473A AT80473A AT323319B AT 323319 B AT323319 B AT 323319B AT 80473 A AT80473 A AT 80473A AT 80473 A AT80473 A AT 80473A AT 323319 B AT323319 B AT 323319B
Authority
AT
Austria
Prior art keywords
freezer
concentration
medicinal products
high molecular
low molecular
Prior art date
Application number
AT80473A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of AT323319B publication Critical patent/AT323319B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4853—Kallikrein (3.4.21.34 or 3.4.21.35)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/02—Crystallisation from solutions
    • B01D9/04—Crystallisation from solutions concentrating solutions by removing frozen solvent therefrom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AT80473A 1972-02-01 1973-01-30 Verfahren zur gefrierkonzentrierung von wässerigen lösungen niedermolekularer oder höhermolekularer arzneimittel AT323319B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2204598A DE2204598A1 (de) 1972-02-01 1972-02-01 Anwendung eines verfahrens zur gefrierkonzentrierung von waessrigen loesungen von arzneimitteln

Publications (1)

Publication Number Publication Date
AT323319B true AT323319B (de) 1975-07-10

Family

ID=5834656

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80473A AT323319B (de) 1972-02-01 1973-01-30 Verfahren zur gefrierkonzentrierung von wässerigen lösungen niedermolekularer oder höhermolekularer arzneimittel

Country Status (9)

Country Link
US (1) US3897409A (de)
JP (1) JPS4884082A (de)
AT (1) AT323319B (de)
BE (1) BE794743A (de)
DE (1) DE2204598A1 (de)
FR (1) FR2170135B1 (de)
GB (1) GB1410541A (de)
NL (1) NL7301244A (de)
PL (1) PL89089B1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9527540B2 (en) 2011-07-15 2016-12-27 Revolights, Inc. Bicycle lighting systems and methods
US8337060B1 (en) 2011-07-15 2012-12-25 John Kent Frankovich Bicycle lighting systems and methods
US9227559B2 (en) 2012-12-31 2016-01-05 Revolights, Inc. Vehicle lighting control system and method
US8956542B1 (en) * 2013-07-30 2015-02-17 Showa Freezing Plant Co., Ltd. Method for processing radioactively-contaminated water
CA2922828C (en) * 2013-08-29 2023-01-03 Meiji Co., Ltd. Production method for concentrated product using freeze-concentration method
US10393365B2 (en) 2017-04-05 2019-08-27 Revolights, Inc. Wheelchair lighting systems and methods
CN111646923B (zh) * 2020-06-18 2022-11-15 山西省科技资源与大型仪器开放共享中心 一种冷冻浓缩提纯羟基乙腈的方法

Also Published As

Publication number Publication date
FR2170135B1 (de) 1977-02-04
BE794743A (fr) 1973-07-30
FR2170135A1 (de) 1973-09-14
US3897409A (en) 1975-07-29
JPS4884082A (de) 1973-11-08
DE2204598A1 (de) 1973-08-09
GB1410541A (en) 1975-10-15
NL7301244A (de) 1973-08-03
PL89089B1 (de) 1976-10-30

Similar Documents

Publication Publication Date Title
AT287205B (de) Verfahren zur Herstellung von Arzneimittelzubereitungen
ATA398673A (de) Verfahren zur herstellung injizierbarer praparate des tc99m-ions oder in113m-ions
AT329780B (de) Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
ATA916173A (de) Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
AT333448B (de) Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
AT327190B (de) Verfahren zur herstellung von 1-hydroxi-2-pyridonen
AT326668B (de) Verfahren zur herstellung von chinazolinonderivaten
AT323319B (de) Verfahren zur gefrierkonzentrierung von wässerigen lösungen niedermolekularer oder höhermolekularer arzneimittel
AT325764B (de) Verfahren zur herstellung von 3-carbamoyloxymethylcephalosporinen
AT321891B (de) Verfahren zur herstellung von 2-alkoxy-5-alkyl-sulfonylbenzoesäuren
AT331393B (de) Verfahren zur herstellung von 7-amino-desacetoxycephalosporansaure
AT319931B (de) Verfahren zur Herstellung von N-(1-Äthyl-α-pyrrolidylmethyl)-2-methoxy-5-sulfamidobenzamid
AT320627B (de) Verfahren zur Herstellung von α-Deoxytetracyclinen
AT321268B (de) Verfahren zur Herstellung von m- und p-Phenylendiamin
DE2316050A1 (de) Verfahren zur herstellung von 2-hydroxyaethylimino-diacetonitril und 2-hydroxyaethylimino-diacetaten
AT329536B (de) Verfahren zur herstellung von 2-alkoxy-5-alkylsulfonylbenzoesauren
AT326097B (de) Verfahren zur herstellung von 3-fluor-d-alanin
AT336009B (de) Verfahren zur herstellung von 2-amino-2-oxazolinen
AT328456B (de) Verfahren zur herstellung von chinazolinonderivaten
AT326096B (de) Verfahren zur herstellung von 3-fluor-d-alanin
AT325786B (de) Verfahren zur herstellung von eburnamoninen
AT324294B (de) Verfahren zur herstellung von 3-fluor-d-alanin
AT326648B (de) Verfahren zur herstellung von 2-nitro-benzofuranderivaten
ATA997673A (de) Verfahren zur herstellung von 4-chlor-2-hydroxybenzothiazol
CH529107A (de) Verfahren zur Herstellung von Adamantylcarboxamidophenylessigsäuren oder Derivaten derselben

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee